Angiotensin receptor blockers – irbesartan

Last updated on August 27, 2024

Generic name

irbesartan, including in combination with hydrochlorothiazide

Strength

75 mg, 150 mg, 300 mg, 150 mg/12.5 mg, 300 mg/12.5 mg, 300 mg/25 mg
Form tablet

Criteria

Approval period

  1. Person identified as experiencing intractable cough or angioedema on an Angiotensin Converting Enzyme Inhibitor (ACE-I).

    AND
     
  2. Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan.

Indefinite

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • Individuals requiring a diuretic combination product must satisfy the same criteria.

Special Authority request form(s)